You are here

US researchers using nanotech, gene editing to turn off cholesterol gene in mice


RESEARCHERS in the US have used nanotechnology plus the powerful CRISPR-Cas9 gene editing tool to turn off a key cholesterol-related gene in mouse liver cells, an advance that could lead to new ways to correct genes that cause high cholesterol and other liver diseases.


Market voices on: